Cell-Cycle Control of Developmentally Regulated Transcription Factors Accounts for Heterogeneity in Human Pluripotent Cells

por Singh, Amar M., Chappell, James, Trost, Robert, Lin, Li, Wang, Tao, Tang, Jie, Matlock, Brittany K., Weller, Kevin P., Wu, Hao, Zhao, Shaying, Jin, Peng, Dalton, Stephen
Publicado 2014

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

por Monsalvo, Ana Clara, Batalle, Juan P., Lopez, M. Florencia, Krause, Jens C., Klemenc, Jennifer, Zea, Johanna, Maskin, Bernardo, Bugna, Jimena, Rubinstein, Carlos, Aguilar, Leandro, Dalurzo, Liliana, Libster, Romina, Savy, Vilma, Baumeister, Elsa, Aguilar, Liliana, Cabral, Graciela, Font, Julia, Solari, Liliana, Weller, Kevin P., Johnson, Joyce, Echavarria, Marcela, Edwards, Kathryn M., Chappell, James D., Crowe, James E., Williams, John V., Melendi, Guillermina A., Polack, Fernando P.
Publicado 2010

TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

por Song, No-Joon, Allen, Carter, Vilgelm, Anna E., Riesenberg, Brian P., Weller, Kevin P., Reynolds, Kelsi, Chakravarthy, Karthik B., Kumar, Amrendra, Khatiwada, Aastha, Sun, Zequn, Ma, Anjun, Chang, Yuzhou, Yusuf, Mohamed, Li, Anqi, Zeng, Cong, Evans, John P., Bucci, Donna, Gunasena, Manuja, Xu, Menglin, Liyanage, Namal P.M., Bolyard, Chelsea, Velegraki, Maria, Liu, Shan-Lu, Ma, Qin, Devenport, Martin, Liu, Yang, Zheng, Pan, Malvestutto, Carlos D., Chung, Dongjun, Li, Zihai
Publicado 2021

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

por Song, No-Joon, Allen, Carter, Vilgelm, Anna E., Riesenberg, Brian P., Weller, Kevin P., Reynolds, Kelsi, Chakravarthy, Karthik B., Kumar, Amrendra, Khatiwada, Aastha, Sun, Zequn, Ma, Anjun, Chang, Yuzhou, Yusuf, Mohamed, Li, Anqi, Zeng, Cong, Evans, John P., Bucci, Donna, Gunasena, Manuja, Xu, Menglin, Liyanage, Namal P. M., Bolyard, Chelsea, Velegraki, Maria, Liu, Shan-Lu, Ma, Qin, Devenport, Martin, Liu, Yang, Zheng, Pan, Malvestutto, Carlos D., Chung, Dongjun, Li, Zihai
Publicado 2022

Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy

por Azar, Joseph H., Evans, John P., Sikorski, Madison H., Chakravarthy, Karthik B., McKenney, Selah, Carmody, Ian, Zeng, Cong, Teodorescu, Rachael, Song, No-Joon, Hamon, Jamie L., Bucci, Donna, Velegraki, Maria, Bolyard, Chelsea, Weller, Kevin P., Reisinger, Sarah A., Bhat, Seema A., Maddocks, Kami J., Denlinger, Nathan, Epperla, Narendranath, Gumina, Richard J., Vlasova, Anastasia N., Oltz, Eugene M., Saif, Linda J., Chung, Dongjun, Woyach, Jennifer A., Shields, Peter G., Liu, Shan-Lu, Li, Zihai, Rubinstein, Mark P.
Publicado 2023